Cleared Special

K101457 - EASYPLUS MINI R9N SELF MONITORING BLOOD GLUCOSE SYSTEM MODEL EPS10031
(FDA 510(k) Clearance)

Jul 2010
Decision
36d
Days
Class 2
Risk

K101457 is an FDA 510(k) clearance for the EASYPLUS MINI R9N SELF MONITORING BLOOD GLUCOSE SYSTEM MODEL EPS10031. This device is classified as a System, Test, Blood Glucose, Over The Counter (Class II - Special Controls, product code NBW).

Submitted by Eps Bio Technology Corp. (Hsinchu City, Hsinchu, TW). The FDA issued a Cleared decision on July 1, 2010, 36 days after receiving the submission on May 26, 2010.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.

Submission Details

510(k) Number K101457 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 2010
Decision Date July 01, 2010
Days to Decision 36 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code NBW — System, Test, Blood Glucose, Over The Counter
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1345

Similar Devices — NBW System, Test, Blood Glucose, Over The Counter

All 507
On Call? Sure GK Blood Glucose & Ketone Monitoring System; On Call? Sure Sync GK Blood Glucose & Ketone Monitoring System
K250085 · ACON Laboratories, Inc. · Oct 2025
TeleRPM Gen2 Blood Glucose Monitoring System
K243060 · Guangdong Transtek Medical Electronics Co., Ltd. · Jan 2025
RIGHTEST Blood Glucose Monitoring System Max Tel
K240637 · Bionime Corporation · Nov 2024
Sejoy Blood Glucose Monitoring System; Sejoy Advance Link Blood Glucose Monitoring System
K240640 · Sejoy Biomedical Co., Ltd. · Oct 2024
CONTOUR? PLUS BLUE Blood Glucose Monitoring System; CONTOUR? NEXT GEN Blood Glucose Monitoring System
K241787 · Ascensia Diabetes Care U.S., Inc. · Aug 2024
VivaChek? Fad Blood Glucose Monitoring System, VivaChek? Fad Smart Blood Glucose Monitoring System, VivaChek? Fad Sync Blood Glucose Monitoring System
K222126 · Vivachek Biotech (Hangzhou) Co., Ltd. · Aug 2024